Jade Biosciences
The Medical Director is a senior clinical role supporting Jade Biosciences’ clinical development programs and providing medical leadership across studies. The position reports to the Senior Medical Director and contributes to program-level decision making. This is a fully remote role with occasional travel to team and company events.
Jade Biosciences is a clinical-stage biotechnology company on a mission to transform the standard of care for patients with autoimmune diseases. The company develops a pipeline of potentially best-in-class therapies built on discovery-stage assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. Its lead candidate, JADE101, is designed to inhibit the cytokine APRIL and is being developed for the treatment of immunoglobulin A nephropathy (IgAN).
Zacks Research Downgrades Jade Biosciences (NASDAQ:JBIO) to Strong Sell
11 hours ago
Guggenheim raises Jade Biosciences stock price target on pipeline progress
1 day ago
Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Jade Biosciences.
Jade Biosciences Announces $135 Million Private Placement
Oct 7, 2025
Senior Global Development Medical Director
AstraZeneca
Medical Director
Iovance Biotherapeutics
Executive Medical Director, Clinical Development, Neurodegeneration
Neurocrine Biosciences
Senior Medical Director, Clinical Development, Neurology
Neurocrine Biosciences
SD/ED, Medical Director MD, Endocrinology
Neurocrine Biosciences
Senior Medical Director, Immunology Clinical Development
AbbVie